ThePrint podcast

ThePrintPod: India’s draft guidelines on biosimilar drugs can make treatments more accessible, affordable

30.7.2025
0:00
7:37
15 Sekunden vorwärts
15 Sekunden vorwärts
Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.  

Weitere Episoden von „ThePrint“